Boardroom Alpha
Boardroom Alpha
NVEC · Additional Proxy Materials (DEFA14A) · Filed June 22, 2026

Nve Corp — Additional Proxy Materials (DEFA14A)

Form
DEFA14A
Filed
June 22, 2026
Ticker
NVEC
Accession
0000724910-26-000001
Boardroom Alpha · Filing insights

NVE Corporation announces leadership transition: Pete Eames to become CEO; board expands with Carolyn Valentine nomination.

About Nve Corp
Market cap
$517M
1Y TSR
+95.3%
3Y TSR
+19.6%
Board grade
C+
Sector
Technology
CEO
Peter G. Eames
Last annual meeting: Aug 6, 2026 · View full Nve Corp profile →
 


 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549
_______________

SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934
(Amendment No.   )
Filed by the Registrant  ☑
Filed by a party other than the Registrant  ☐
 
Check the appropriate box:
Preliminary Proxy Statement
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
Definitive Proxy Statement
Definitive Additional Materials
Soliciting Material under § 240.14a-12
 
NVE Logo
NVE Corporation

(Name of Registrant as Specified In Its Charter)
 
 
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
 
Payment of Filing Fee (Check all boxes that apply):
No fee required.
   
Fee paid previously with preliminary materials.
   
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11
   
   
   
   

 

Small NVE logo
11409 Valley View Road
Eden Prairie, MN 55344-3617
www.nve.com

 
Fellow Shareholders,

As I noted in last year’s letter, we expected to begin seeing the returns on our investments in capacity and product development-and this past fiscal year, we did exactly that. In our most recent quarter, net income increased 27%, driven by a 34% increase in our core non-defense sales.

Expansion Completed
During the past fiscal year, we substantially completed our two-year, multimillion-dollar expansion, which included construction and advanced manufacturing equipment. The expansion increased our production capacity, improved our capabilities, and allowed us to manufacture even smaller and more precise Wafer-Level Chip Scale Packaged parts.

Four Key Growth Markets
We are well positioned in four important growth markets: medical devices, robotics, the Internet of Things / Artificial Intelligence of Things, and power conversion. Our parts’ small size and ultralow power consumption make them ideal for medical devices. Precision and size are important for robotics applications. The Internet of Things and Artificial Intelligence of Things depend on ubiquitous sensors for information. And emerging power conversion applications-including hybrid and electric vehicles, green energy systems, and data centers-continue to create exciting opportunities for our technology.

Research and Development
Our R&D strategy is to turn state-of-the-art technology into world-class products for high-value markets. We continued to execute on that strategy with a steady stream of new products over the past year. Among the highlights were several new Wafer-Level Chip Scale sensors that are smaller and more spatially sensitive than conventional sensors, enabling smaller medical devices and especially precise robotics.

Beyond product launches, we continued investing in advanced R&D initiatives with long-term potential, including next-generation MRAM for antitamper applications; next-generation sensors for medical devices; and ultrahigh-sensitivity sensors for advanced human interfaces.

Sales and Marketing
We continued building demand for our products through compelling demonstrations, expanded tradeshow participation, and the addition of a new distributor to our worldwide network.

Management and Board Changes
This is my 25th—and final—letter to shareholders as NVE’s president and CEO. Leading this company has been the privilege of a lifetime.

At our upcoming Annual Meeting, Pete Eames will take over as president and CEO. I’m confident in the company’s future under Pete’s leadership. Pete brings extraordinary experience, dedication, and judgment, and I know shareholders will be well-served by his leadership.

I look forward to continuing to serve NVE as Board chairman. Terry Glarner will retire as chairman and remain on the Board, and we are grateful for his many years of leadership and service.

We have also nominated a new director, Carolyn Valentine, whose experience and perspective make her exceptionally well qualified. Expanding the Board will further strengthen the company as we continue to grow.

Thank you for your continued support and confidence over the years. I am proud of our team’s accomplishments and excited for opportunities ahead as NVE enters its next chapter.

Sincerely,
 
-s- Daniel A. Baker
Daniel A. Baker
President and Chief Executive Officer
 
Statements in this letter that relate to future plans, events, or performance are forward-looking statements that are subject to certain risks and uncertainties including the risk factors listed from time to time in our filings with the SEC, including our Annual Report on Form 10-K for the fiscal year ended March 31, 2026. Actual results could differ materially from the information provided, and we undertake no obligation to update forward-looking statements.

From this filing to the vote

Forecast every director vote the day the proxy files.

Meeting Forecast scores each director up for re-election + every contested situation, rebuilt daily across 6,000+ U.S. public companies. The same model that called the LULU contested proxy lives on every meeting you see here.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Nve Corp (NVEC)

Reference

Frequently asked questions

When did Nve Corp file this DEFA14A?
Nve Corp (NVEC) filed this Additional Proxy Materials (DEFA14A) with the SEC on June 22, 2026. The accession number assigned by EDGAR is 0000724910-26-000001.
What does a DEFA14A disclose?
DEFA14A is additional definitive proxy soliciting material filed in connection with a shareholder meeting — supplemental letters, slides, or amendments issued after the main proxy statement.
What is the key takeaway from this filing?
NVE Corporation announces leadership transition: Pete Eames to become CEO; board expands with Carolyn Valentine nomination. This is Boardroom Alpha's one-line summary of the additional proxy materials; see the full filing text above for the formal disclosure.
Where can I find Nve Corp's prior proxy statements on EDGAR?
The SEC EDGAR browser lists every DEFA14A Nve Corp has filed under CIK 724910, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer